Remove Ethics Remove Leads Remove Patients Remove Safety
article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. This could lead to false positives or, even worse, false negatives!

Ethics 85
article thumbnail

Janssen leads effort to cut waste in digital health devices

pharmaphorum

Devices such as smart pill boxes, electronic blood collection devices, wearable monitors, and intelligent labels are increasingly being used to improve healthcare efficiency and conditions for patients, but present an “expanding e-waste challenge.” Photo by Possessed Photography on Unsplash.

Leads 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Artificial Intelligence Could Be the Ultimate Weapon Against Cancer

MedCity News

With the rise of AI technologies, we could see significant advancements in cancer treatment, making it more efficient and potentially leading to a cure. By catching the disease early, patients have a higher chance of receiving successful treatment, and the cost of treatment can be significantly reduced.

article thumbnail

How clinical outcome assessments can help us understand the patient experience

Clarivate

Clinical outcome assessments can take years to generate but may pay big dividends in patient-focused drug development, centering the patient experience and potentially bolstering a product’s case with regulators and payers. A clinical outcome assessment is a measure that describes or reflects how a patient feels, functions or survives.

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

If data used to support the safety , efficacy and quality of pharmaceutical products is compromised or unreliable, it can lead to regulatory non-compliance, product recalls, and most importantly, harm to patients who depend on those medications. What is the greatest current challenge in maintaining data integrity?

article thumbnail

The Future of Medical Sales Careers: Trends, Challenges, and Opportunities

Rep-Lite

From groundbreaking advancements in technology to a growing emphasis on patient-centricity, the industry is constantly evolving. Don’t get it wrong, these are all aimed at ensuring patient safety, transparency, and ethical standards. The world of medical sales is bursting with change.

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

The rule aims to regulate and enhance the transparency, effectiveness, and safety of predictive DSIs used in healthcare settings, ensuring that these technologies are developed and managed responsibly. Effective: Ensures that DSIs achieve their intended outcomes, improving clinical decision-making and patient care.